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December 20121816 Abstractshemodynamics, which may enhance outcomes and reduce secondary
interventions for recurrent stenosis.
Table. Hemodynamic parameters
Variable 30-day duplex scan Most recent duplex scan
50%
DR
50-75%
DR
75%
DR
50%
DR
50-75%
DR
75%
DR
Angio alone, No.
(%)
152 15 (9) 0 141 21 (13) 5 (3)
Mean PSV (cm/s) 98  46 198  47 . . . 106  38 204  51 422  45
Angio  IVUS,
No. (%)
233 8 (3) 0 232 8 (3) 1 (0.4)
Mean PSV (cm/s) 84  50 182  31 . . . . 82  40 186  28 347
Stress Tests Are Overutilized in the Preoperative Evaluation of Endo-
vascular Aneurysm Repair
Siddharth Patel, Richard Gilmore, Yazan Duwayri, Ravi Rajani, James
Reeves, Luke Brewster, Thomas Dodson, Ravi Veeraswamy. Emory Uni-
versity School of Medicine, Atlanta, Ga
Introduction: The ideal approach for cardiac risk stratification in patients
undergoing elective endovascular aortic aneurysm repair (EVAR) remains un-
resolved. Multiple algorithms are used to evaluate patients, with significant
variability amongst institutions, and cardiac stress testing remains a widely used
modality. Recent American College of Cardiology/American Heart Associa-
tion guidelines suggest clinical risk factors can identify patients at highest risk for
adverse events. We compared the clinical efficacy and cost-savings of risk factor
assessment using the revised cardiac risk index (RCRI) vs cardiac stress testing in
predicting perioperative cardiac complications after EVAR.
Methods: A single-center retrospective study was conducted to identify
patients undergoingEVARbetween 2009 and 2011.Of 248 patients whowere
identified, 42 were excluded due to emergent repair, and 206 patients were
included in the analysis. The preoperative assessment was identified and a cost
analysis was performed based on CMS reimbursement rates for our geographic
area. The RCRI was calculated for each patient and used to stratify them
according to predicted risk for a perioperative cardiac event. The 30-day event
rates for death or symptomatic cardiac events were calculated.
Results: Complete records for preoperative evaluations were available
for 197 of the 206 patients. Of those, 168 (85%) underwent cardiac stress
testing, of which 26 patients (13%) were positive, resulting in further testing.
Twenty patients with a positive stress test underwent cardiac catheterization,
three underwent percutaneous coronary intervention (PCI), and one under-
went coronary artery bypass grafting. There were no perioperative deaths.
Six patients (2.9%) had clinical symptoms prompting measurement of serum
troponin levels, which were elevated. In patients with a negative stress test,
five myocardial infarctions (MIs) occurred (3%) vs one MI in patients with a
positive stress test (3.8%; P  .86). When stratified by the RCRI, patients
with fewer than three risk factors had anMI rate of 2.5% vs 16.7% in patients
with three or more factors (P .04). Including the resultant procedures, the
per-patient cost for routine preoperative stress testing was $3500.
Conclusions: Routine preoperative cardiac stress testing for patients
undergoing elective endovascular aneurysm repair is unwarranted. It results
in additional invasive testing and therapy with a concomitant cost increase.
The RCRI is a reliable tool for risk stratification and guiding preoperative
workup in patients scheduled for elective EVAR. The RCRI should replace
qualitative physician determination of fitness for EVAR. This represents a
potential area for improved resource utilization strategies.
Table. Stress test and perioperative MI by risk score
RCRI risk score
Stress test, No. (%) MI, No. (%)
Yes No. Yes No.
3 163 (85) 28 (15) 5 (2.5) 195 (97.5)
3 5 (83) 1 (17) 1 (17) 5 (83)
Percutaneous Endovascular Aortic Aneurysm Repair (PEVAR): Re-
sults From the First Prospective, Multicenter Randomized Trial
Peter R. Nelson. University of Florida College of Medicine, Gainesville, Fla
Introduction: The first randomized controlled trial was designed and
conducted to assess the safety and effectiveness of totally percutaneous
endovascular aortic aneurysm repair (PEVAR) using a 21F endovascular
stent graft system and an 8F or 10F suture-mediated closure system. A
noninferiority trial design was chosen to compare percutaneous access to
standard open femoral exposure.Methods: Between 2010 and 2012, 20 United States institutions
participated in a prospective, U.S. Food and Drug Administration-approved
a
sandomized trial to evaluate the safety and effectiveness of percutaneous
emoral artery access and closure using a “preclose” technique in conjunc-
ion with EVAR. A total of 192 patients were enrolled, 41 in a nonrandom-
zed roll-in phase, and then 151 in the randomized phase where patients
ere allocated 2:1 to percutaneous closure (group C, n  101) or open
emoral exposure (group S, n  50). PEVAR procedures were performed
sing the 8F Perclose ProGlide (group C1, n  50) or the 10F Prostar XL
group C2, n  51) closure device. All EVAR procedures were performed
ith the 21F profile IntuiTrak System. Patients were screened using com-
uted tomography with 3-dimensional reconstruction and independent
hysician review for anatomic suitability and adequate femoral artery anat-
my for percutaneous access (eg, absence of anterior wall or circumferential
alcification, aneurysm, or extensive scarring). Primary treatment success
as defined as procedural technical success and absence of adverse systemic
nd access-related vascular events at 30 days. Secondary clinical utility and
rocedural outcomes, ankle-brachial index, blood laboratory analyses, and
uality of life were also evaluated with continuing follow-up to 6 months.
Results: Baseline characteristics were similar among all groups. EVAR
echnical success was 100%, 100%, and 98% in groups C1, C2, and S,
espectively. Primary treatment success at 1 month was 88% (C1), 78% (C2),
nd 78% (S) with a one-sided Blackwelder’s test of noninferiority yielding
 .0036 for C1 vs S and P  .1021 for C2 vs S. Secondary outcomes
rocedurally to within 1 month are shown in the Table. PEVAR (group C)
ompared favorably with respect to time to hemostasis, anesthesia time, total
rocedure time, analgesic use, ipsilateral groin pain, blood transfusion require-
ent, and quality of life metrics. Final 6-month follow-up is ongoing.
Conclusions: Among trained operators and patients with suitable femo-
al artery anatomy, a totally percutaneous approach to EVAR is safe, with
inimal access-related complications. The ProGlide suture-mediated device
pecifically performed noninferiorly to standard open femoral exposure. Train-
ng, experience, and careful application of the “preclose” technique is of para-
ount importance in ensuring successful, sustainable outcomes.
able.
utcome measure Group C1 Group C2 Group S
nesthesia time, minutes 181  65 152  54a 203  93
ime to hemostasis, minutes 9.8  17a 13  19a 23  23
otal procedure Time, minutes 101  43a 95  35a 136  71
stimated blood loss, mL 213  205 193  198 280  290
lood transfusion, % patients 4.0% 16% 14%
ime to ambulation, hours 17  7.2 16  9.1 19  16
ime to normal diet, hours 14  9.4 10  8.4 15  22
psilateral groin pain
pre-dischargeb
2.1  2.2 1.4  2.0a 2.6  2.4
nalgesics for groin pain
pre-discharge, % patients
18% 12%a 30%
ime to hospital discharge, days 1.3  0.7 1.4  0.9 1.8  2.4
psilateral groin pain at 1
monthb
0.4  0.9 0.1  0.5a 0.6  1.5
F-36 health-related quality of
life change at 1 month
9.4  26 8.3  29 1.6  24
psilateral ankle-brachial index
at 1 month
1.06  0.16 1.05  0.15 1.06  0.13
esults shown as mean  SD unless otherwise specified.
P.05 vs group S result.
Scale of 0 (no pain) to 10 (worst pain imaginable).
equential Catheterization Amid Progressive Endograft Deployment
or Fenestrated and Branched Endovascular Aortic Aneurysm Repair
regory A. Stanley, Carlos H. Timaran, M. Shadman Baig, J. Gregory
odrall, David E. Timaran, L. F. Gomez, R. James Valentine. University of
exas Southwestern, Dallas, Tex
Introduction: Fenestrated and branched endovascular aneurysm repair
FEVAR) is an alternative to open repair of complex aortic aneurysms in
igh-risk patients. Unfortunately, patients with unfavorable anatomy are fre-
uently denied FEVAR because of the risk of technical failure with loss of
isceral arteries. The purpose of this study was to assess technical success of
EVAR using a sequential catheterization amid progressive endograft deploy-
ent (SCAPED) technique, particularly in patients with unfavorable anatomy.
Methods: During a 12-month period, 39 high-risk patients (31 men
nd 8 women) underwent FEVAR using customized, physician-modified
enith endografts that were fenestrated or branched using the SCAPED
echnique. The visceral vessels were sequentially catheterized through the
enestrations via left brachial artery access in a cranial-to-caudal direction as
he endograft was progressively deployed. Each fenestration was deployed,
ligned, and catheterized separately while the distal endograft was con-
trained within the delivery sheath. Technical success was defined as com-
